SHARE

Sanofi and CD&R sign agreement for sale of Opella

Sanofi and the US fund Clayton Dubilier & Rice (CD&R) announced the signing of an agreement for the purchase of shares in Opella, Sanofi’s consumer health division. The deal will allow CD&R to acquire a controlling 50% stake in the Doliprane manufacturer.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.